Dr. Kathryn C. Hourdequin
Claim this profileDartmouth Hitchcock Medical Center/Dartmouth Cancer Center
Studies Cancer
Studies Adenocarcinoma
18 reported clinical trials
34 drugs studied
About Kathryn C. Hourdequin
Education:
- Earned an MD from Geisel School of Medicine at Dartmouth in 2009.
- Obtained a PhD in Pharmacology and Toxicology from Dartmouth College in 2009.
Experience:
- Serves as an Assistant Professor of Medicine at the Geisel School of Medicine at Dartmouth.
- Works as a Medical Oncologist at Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center.
- Completed residency in Internal Medicine and fellowship in Hematology/Oncology at Dartmouth-Hitchcock Medical Center.
Area of expertise
1Cancer
Stage IV
Stage III
PD-L1 positive
2Adenocarcinoma
Stage IV
dMMR negative
MSI-H negative
Affiliated Hospitals
Clinical Trials Kathryn C. Hourdequin is currently running
Atezolizumab + Chemotherapy
for Neuroendocrine Carcinoma
This trial is testing a new treatment combining an immune-boosting drug with standard chemotherapy for patients with a specific type of aggressive cancer that has spread. The goal is to help the immune system fight the cancer and use chemotherapy to kill cancer cells.
Recruiting1 award Phase 2 & 310 criteria
Chemotherapy + Bevacizumab + Atezolizumab
for Colorectal Cancer
This phase III trial studies how well combination chemotherapy, bevacizumab, and/or atezolizumab work in treating patients with deficient deoxyribonucleic acid (DNA) mismatch repair colorectal cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as fluorouracil, oxaliplatin, and leucovorin calcium, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bevacizumab may stop or slow colorectal cancer by blocking the growth of new blood vessels necessary for tumor growth. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving combination chemotherapy, bevacizumab, and atezolizumab may work better in treating patients with colorectal cancer.
Recruiting2 awards Phase 31 criteria
More about Kathryn C. Hourdequin
Clinical Trial Related4 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Kathryn C. Hourdequin has experience with
- Fluorouracil
- Cisplatin
- Bevacizumab
- Ipilimumab
- Nivolumab
- Leucovorin Calcium
Breakdown of trials Kathryn C. Hourdequin has run
Cancer
Adenocarcinoma
Neuroendocrine Carcinoma
Neuroendocrine Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kathryn C. Hourdequin specialize in?
Kathryn C. Hourdequin focuses on Cancer and Adenocarcinoma. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Kathryn C. Hourdequin currently recruiting for clinical trials?
Yes, Kathryn C. Hourdequin is currently recruiting for 11 clinical trials in Lebanon New Hampshire. If you're interested in participating, you should apply.
Are there any treatments that Kathryn C. Hourdequin has studied deeply?
Yes, Kathryn C. Hourdequin has studied treatments such as Fluorouracil, Cisplatin, Bevacizumab.
What is the best way to schedule an appointment with Kathryn C. Hourdequin?
Apply for one of the trials that Kathryn C. Hourdequin is conducting.
What is the office address of Kathryn C. Hourdequin?
The office of Kathryn C. Hourdequin is located at: Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire 03756 United States. This is the address for their practice at the Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.